Systemic Cell Therapy in Early Phase Trials for Diabetic Kidney Disease

Time: 10:30 am
day: Day 2 Track 2 AM


  • Showcasing successful demonstration of feasibility, safety and preliminary efficacy of allogeneic cell therapy for Progressive CKD in a phase 1/2 trial setting
  • Setting the scene for Phase 3 trials in US, Japan & EU
  • Evaluating how close this is to widespread commercial/ clinical reality